Visterra (Cambridge, MA), a preclinical-stage biotechnology company focused on seasonal and pandemic influenza, closed a $13M Series A financing, bringing the total round to $26M. Participants include The Bill & Melinda Gates Foundation, Omega Funds, Polaris Venture Partners, Flagship Ventures and Lux Capital.
Collective IP | The World’s Largest Technology Transfer Office Marketplace
Providing Unrivaled Comprehensive and Accurate Access to Humankinds Most Valuable and Transformative Assets
Receive Collective IP Account Access HERE